1 Like
Indirect methods to boost endogenous Tristetraprolin (TTP) expression or stabilize its protein involve targeting the cellular pathways that regulate its production and activity.
1. Increasing TTP Expression
Several agents can induce the transcription of the ZFP36 gene:
- Glucocorticoids : Potently upregulate TTP expression, contributing to their anti-inflammatory effects.
- β2-Adrenoreceptor Agonists : Drugs like salbutamol increase TTP mRNA and protein levels in macrophages via cAMP signaling.
- cAMP-elevating agents : Forskolin (an adenylate cyclase activator) and phosphodiesterase (PDE) inhibitors (e.g., rolipram) boost TTP expression through the cAMP pathway.
- Natural Compounds : Substances like resveratrol (found in grapes) and cinnamon polyphenol extract have been shown to increase TTP levels in experimental models.
2. Stabilizing and Activating TTP Protein
The primary method is preventing its inactivation by phosphorylation:
- Inhibiting MK2 Kinase : The p38 MAPK/MK2 pathway phosphorylates TTP, leading to its inactivation and binding to 14-3-3 proteins. Inhibiting this pathway keeps TTP active.
- Activating Protein Phosphatase 2A (PP2A) : PP2A dephosphorylates TTP, restoring its mRNA-destabilizing function. Small molecules like arctigenin act as PP2A agonists, enhancing TTP’s anti-inflammatory activity.